{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:09:23Z","timestamp":1791882563887,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010638","name":"Huntsman Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007558","name":"Rutgers Cancer Institute of New Jersey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ijrobp.2020.03.020","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T11:04:29Z","timestamp":1586603069000},"page":"694-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial"],"prefix":"10.1016","volume":"107","author":[{"given":"Matthew M.","family":"Poppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab A.","family":"Yehia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Toppmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Kirstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Haffty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif J.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.03.020_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy","volume":"337","author":"Overgaard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib2","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82C randomized trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199710023371402","article-title":"Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer","volume":"337","author":"Ragaz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK standardisation of breast radiotherapy (Start) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib6","series-title":"Basic Clinical Radiobiology","first-page":"134","article-title":"The linear-quadratic model in clinical practice","author":"Bentzen","year":"2002"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: A randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib10","first-page":"2037","article-title":"Hypofractionated postmastectomy radiation therapy is safe and effective: First results from a prospective phase ii trial. Journal of clinical oncology: official journal of the American Society of Clinical","volume":"35","author":"Khan","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib11","series-title":"Breast Cancer Atlas for Radiation Therapy Planning: Consensus Definitions","article-title":"Breast cancer atlas for radiation therapy planning: Consensus definitions","author":"White","year":"2011"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib12","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib13","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S0167-8140(15)30629-0","article-title":"OC-0523: Lymph node RT improves survival in breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922\/10925","volume":"11","author":"Poortmans","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib14","article-title":"NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer","volume":"29","author":"Whelan","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijrobp.2016.10.002","article-title":"Nation-scale adoption of shorter breast radiation therapy schedules can increase survival in resource constrained economies: Results from a Markov chain analysis","volume":"97","author":"Khan","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bmj.1.5491.834","article-title":"Radiation-induced peripheral neuropathy","volume":"1","author":"Stoll","year":"1966","journal-title":"Br Med J"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/02841860500371907","article-title":"Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer\u2014a review","volume":"45","author":"Galecki","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/028418600750013140","article-title":"Brachial plexopathy after postoperative radiotherapy of breast cancer patients\u2014a long-term follow-up","volume":"39","author":"Johansson","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/djh297","article-title":"Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20 year results of the British Columbia randomized trial","volume":"97","author":"Ragaz","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib21","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.ijrobp.2012.08.017","article-title":"Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection","volume":"85","author":"Koukourakis","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib22","first-page":"S94","article-title":"A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer","volume":"94","author":"Pinitpatcharalert","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib23","first-page":"282","article-title":"Post mastectomy adjuvant radiotherapy in breast cancer: A comparision of\u00a0three hypofractionated protocols","volume":"59","author":"Shahid","year":"2009","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK standardisation of breast radiotherapy (Start) trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"371","author":"Group","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.020_bib26","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine (US). Identifier NCT03414970, Hypofractionated radiation therapy after mastectomy in preventing recurrence in patients with stage iia-iiia breast cancer; 2018; [about 4 screens]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03414970. Accessed May 1, 2020."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620309482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620309482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:47:50Z","timestamp":1759744070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620309482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0360301620309482"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.03.020","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}